Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection

doi:10.4251/wjgo.v14.i8.1540

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4258)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

127

WORD

HTML

1440

Figures (1-3)

231

Tables (1-5)

280

Sum=2129

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

282

Download

753

Sum=1035

Publishing Process of This Article

Item

Count

Browse

336

Download

758

Sum=1094

Aug 15, 2022 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Aug 15, 2022; 14(8): 1540-1551
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1540

Table 2 5-year survival rate in adjuvant chemoradiotherapy group and adjuvant chemotherapy group

	Group	N	5-yr survival rate (%)	Log rank test
OS	All patietnts			P = 0.010
	Adjuvant chemoradiotherapy group	57	66.7
	Adjuvant chemotherapy group	295	41.9
RFS	All patietnts			P = 0.254
	Adjuvant chemoradiotherapy group	52	64.5
	Adjuvant chemotherapy group	128	55.3
OS	Siewert type II			P = 0.063
	Adjuvant chemoradiotherapy group	25	59.3
	Adjuvant chemotherapy group	123	39.4
RFS	Siewert type II			P = 0.995
	Adjuvant chemoradiotherapy group	22	60.5
	Adjuvant chemotherapy group	58	55.9
OS	Siewert type III			P = 0.006
	Adjuvant chemoradiotherapy group	32	65.7
	Adjuvant chemotherapy group	136	43.9
RFS	Siewert type III			P = 0.082
	Adjuvant chemoradiotherapy group	30	72.6
	Adjuvant chemotherapy group	70	56.8

OS: Overall survival; RFS: Relapse-free survival.

Citation: Kang WZ, Shi JM, Wang BZ, Xiong JP, Shao XX, Hu HT, Jin J, Tian YT. Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection. World J Gastrointest Oncol 2022; 14(8): 1540-1551
URL: https://www.wjgnet.com/1948-5204/full/v14/i8/1540.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i8.1540